Stocktoria
Jaguar Health, Inc. JAGX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-05-13
Jaguar Health, Inc. statistics & valuation
Market cap$1.8M
P / S0.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -398.8% | -263.8% | -351.3% | -287.8% | -939.1% |
| Net margin | -465.4% | -329.3% | -423.1% | -396.9% | — |
| FCF margin | — | -251.5% | — | -277.5% | -806.8% |
| Return on assets | -139.8% | -72.0% | -81.4% | -100.0% | — |
| Return on equity | 286.7% | -592.7% | -843.4% | 3491.8% | — |
| Current ratio | 0.50 | 1.63 | 2.00 | 0.74 | 1.84 |
| Revenue growth | -1.5% | 19.8% | -18.4% | 175.8% | -53.8% |
Source: SEC EDGAR filings · CIK 0001585608 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.